Physician profile
James Kuin
NPI 1972564995
$6,444.08
in general payments reported to CMS, 2019-2025
25 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,275 · 2020: $467 · 2021: $610 · 2022: $292 · 2023: $571 · 2024: $749 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,580.13 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,247.04 | 2019-2025 | Nucala, Arexvy |
| Pfizer INC. | $450.81 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $424.58 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $414.81 | 2023-2025 | Caplyta |
| Abbvie INC. | $344.28 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $262.71 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $234.31 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $229.38 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.20 | 2019-2020 | |
| Allergan, INC. | $165.87 | 2019 | |
| Novo Nordisk INC | $146.58 | 2019 | |
| Merck Sharp & Dohme LLC | $124.81 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $122.69 | 2021 | |
| Paratek Pharmaceuticals, INC. | $119.94 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $103.63 | 2021 | |
| Lilly USA, LLC | $71.69 | 2019 | |
| Circassia INC. | $34.86 | 2019 | |
| Scilex Pharmaceuticals INC. | $32.97 | 2019 | |
| Hologic Sales and Service, LLC | $23.01 | 2024 | Thinprep 2000 Processor, Aptima |
| Radius Health, INC. | $21.45 | 2019 | |
| Astellas Pharma US INC | $20.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.38 | 2019 | |
| Sanofi Pasteur INC. | $19.44 | 2019 | |
| Avion Pharmaceuticals | $15.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kuin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.